Neurocrine Biosciences, Inc. today announced the presentation of new data from a clinician survey highlighting the functional impact experienced by patients with mild tardive dyskinesia (TD) severity ...
Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...
Learn how Huntington’s disease affects mood, including depression, anxiety, apathy, and irritability, plus treatment options and strategies for symptom management.
Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.
Chorea is an abnormal movement characterized by a continuous flow of random muscle contractions. This phenomenon has several causes, such as infectious and degenerative processes. Chorea results from ...
Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...
Deutetrabenazine, used to treat patients with tardive dyskinesia and HD-related chorea, can be administered either once or twice daily. Once-daily extended-release deutetrabenazine (Austedo XR ®), ...
A patient with Advanced Huntington’s Disease has seen amazing results to help improve her involuntary movements (also known as ‘Chorea’) following Nottinghamshire Healthcare’s Specialist Palliative ...
Correspondence to Dr Tamsin Newlove-Delgado, Children and Young People's Mental Health (ChYMe) research collaboration, University of Exeter Medical School, Exeter EX1 2LU, UK; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results